NCT06281691Completed
GreenBladder - Early Detection of Bladder Cancer in Residents in Greenland Using a Urinary Marker and a Mobile Cystoscopy Unit
Source: ClinicalTrials.gov · Last updated 3 Mar 2026
Brief summary (registry, in English)
The goal of this observational study is to evaluate whether a urinary biomarker (Xpert® Bladder Cancer Detection Test) can be used as a selection tool to decide which patients that should undergo cystoscopy in haematuria work-up or in other indications where bladder tumor is suspected. Hereby, the investigators will investigate in which patients where cystoscopy can be omitted, particularly in areas with limited access to urological service. With these more selected investigations, patients with bladder tumors will potentially be selected to earlier diagnosis compared to the current non-selected investigations with the inherent logistic and economical challenges. With this strategy, the investigators aim at improving the current poor prognosis for bladder cancer patients in Greenland.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 127 (actual)
- First submitted
- 30 Jan 2024
- Start date
- 28 Dec 2023
- Primary completion date
- 1 Dec 2025
- Lead sponsor
- Jørgen Bjerggaard Jensen
- Diseases
- Bladder cancer
- NCT number
- NCT06281691
What you commit to
- Study type: Observational
- Participants enrolled: 127
- From 28 Dec 2023 to the primary completion date, 1 Dec 2025
- 2 sites in 2 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Patients not willing to participate.
Who the study is looking for
- ≥18 years of age at the time of signing the Informed Consent Form with an indication for cystoscopy and planned for this already at study inclusion.
- Ability to understand the Participant Information Sheet orally and in writing in either Danish or Greenlandic.
- Signed Informed Consent Form.
- Is, according to the Investigator's judgement, able to comply with the trial protocol.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Department of Urology, Aarhus University Hopsital Coordinator of this site? Confirm its status | Aarhus | Denmark | Unknown status |
| Queen Ingrid's Hospital Coordinator of this site? Confirm its status | Nuuk | Greenland | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.